127 related articles for article (PubMed ID: 30383987)
41. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
[TBL] [Abstract][Full Text] [Related]
42. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
[TBL] [Abstract][Full Text] [Related]
43. Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.
Quintero E; Carrillo M; Leoz ML; Cubiella J; Gargallo C; Lanas A; Bujanda L; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Morillas JD; Balaguer F; Muriel A;
PLoS Med; 2016 May; 13(5):e1002008. PubMed ID: 27138769
[TBL] [Abstract][Full Text] [Related]
44. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
[TBL] [Abstract][Full Text] [Related]
45. Type 2 diabetes mellitus: the impact on colorectal adenoma risk in women.
Elwing JE; Gao F; Davidson NO; Early DS
Am J Gastroenterol; 2006 Aug; 101(8):1866-71. PubMed ID: 16790036
[TBL] [Abstract][Full Text] [Related]
46. Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.
de Kort S; Simons CC; van den Brandt PA; Goldbohm RA; Arts IC; de Bruine AP; Janssen-Heijnen ML; Sanduleanu S; Masclee AA; Weijenberg MP
Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):896-903. PubMed ID: 27097356
[TBL] [Abstract][Full Text] [Related]
47. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
[TBL] [Abstract][Full Text] [Related]
48. Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates.
Zaccardi F; Dhalwani NN; Webb DR; Davies MJ; Khunti K
Diabetologia; 2018 Jul; 61(7):1592-1602. PubMed ID: 29717336
[TBL] [Abstract][Full Text] [Related]
49. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
Patel VB; Nahar R; Murray B; Salner AL
Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
[TBL] [Abstract][Full Text] [Related]
50. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
[TBL] [Abstract][Full Text] [Related]
51. 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.
Ekmekcioglu C; Haluza D; Kundi M
Int J Environ Res Public Health; 2017 Jan; 14(2):. PubMed ID: 28134804
[TBL] [Abstract][Full Text] [Related]
52. Diabetes Status and Being Up-to-Date on Colorectal Cancer Screening, 2012 Behavioral Risk Factor Surveillance System.
Porter NR; Eberth JM; Samson ME; Garcia-Dominic O; Lengerich EJ; Schootman M
Prev Chronic Dis; 2016 Feb; 13():E19. PubMed ID: 26851338
[TBL] [Abstract][Full Text] [Related]
53. Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes.
Overbeek JA; Kuiper JG; van der Heijden AAWA; Labots M; Haug U; Herings RMC; Nijpels G
Int J Colorectal Dis; 2019 Feb; 34(2):269-276. PubMed ID: 30421309
[TBL] [Abstract][Full Text] [Related]
54. Colorectal cancer: another complication of diabetes mellitus?
Will JC; Galuska DA; Vinicor F; Calle EE
Am J Epidemiol; 1998 May; 147(9):816-25. PubMed ID: 9583711
[TBL] [Abstract][Full Text] [Related]
55. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis.
Nilsen TI; Vatten LJ
Br J Cancer; 2001 Feb; 84(3):417-22. PubMed ID: 11161410
[TBL] [Abstract][Full Text] [Related]
56. Medical history risk factors for non-Hodgkin's lymphoma in older women.
Cerhan JR; Wallace RB; Folsom AR; Potter JD; Sellers TA; Zheng W; Lutz CT
J Natl Cancer Inst; 1997 Feb; 89(4):314-8. PubMed ID: 9048836
[TBL] [Abstract][Full Text] [Related]
57. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study.
Limburg PJ; Vierkant RA; Fredericksen ZS; Leibson CL; Rizza RA; Gupta AK; Ahlquist DA; Melton LJ; Sellers TA; Cerhan JR
Am J Gastroenterol; 2006 Aug; 101(8):1872-9. PubMed ID: 16790032
[TBL] [Abstract][Full Text] [Related]
58. Cancer and diabetes co-occurrence: A national study with 44 million person-years of follow-up.
Gurney J; Stanley J; Teng A; Krebs J; Koea J; Lao C; Lawrenson R; Meredith I; Sika-Paotonu D; Sarfati D
PLoS One; 2022; 17(11):e0276913. PubMed ID: 36441693
[TBL] [Abstract][Full Text] [Related]
59. Management of colorectal cancer and diabetes.
Yao C; Nash GF; Hickish T
J R Soc Med; 2014 Mar; 107(3):103-9. PubMed ID: 24334910
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
